These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10635)

  • 1. [Certain clinical and theoretical aspects of treatment of cardiac insufficiency].
    Mukharliamov NM
    Ter Arkh; 1976; 48(4):3-8. PubMed ID: 10635
    [No Abstract]   [Full Text] [Related]  

  • 2. [What is certain in the therapy of coronary insufficiency?].
    Michel D
    Fortschr Med; 1972 Sep; 90(25):889-92. PubMed ID: 4404925
    [No Abstract]   [Full Text] [Related]  

  • 3. [So-called coronary drugs].
    Gamski M
    Kardiol Pol; 1982; 25(2):163-8. PubMed ID: 6125622
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacotherapy of myocardial ischemia.
    Gorlin R
    Major Probl Intern Med; 1976; 11():232-62. PubMed ID: 10490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disputable problems concerning the use of certain methods of treatment of cardiovascular diseases].
    Chazov EI
    Ter Arkh; 1975; 47(5):33-44. PubMed ID: 240212
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ambulatory treatment of chronic coronary insufficiency].
    Trifunović S
    Med Pregl; 1973; 26(9):355-7. PubMed ID: 4152544
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of ischemic heart disease with "coronary drugs" (author's transl)].
    Heinecker R
    MMW Munch Med Wochenschr; 1977 Jan; 119(1):7-10. PubMed ID: 13298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapy of coronary insufficiency].
    Hilger HH; Tauchert M
    Internist (Berl); 1977 Jun; 18(6):315-21. PubMed ID: 18424
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacology of nitrites and adrenergic beta blockaders in coronary circulation].
    Méndez R
    Arch Inst Cardiol Mex; 1980; 50(3):283-88. PubMed ID: 6107070
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of anti-ischemia treatment in man].
    Dupuis B; Vincent A; Lablanche JM
    Arch Mal Coeur Vaiss; 1987 Dec; 80 Spec No():73-6. PubMed ID: 2895620
    [No Abstract]   [Full Text] [Related]  

  • 11. [Problems of combined therapy with cardiac glycosides and anti-anginal drugs (author's transl)].
    Klaus W
    Arzneimittelforschung; 1977; 27(3a):731-6. PubMed ID: 17417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapy for hypertension and ischemic heart disease.
    Kirby B
    Int Anesthesiol Clin; 1980; 18(4):25-51. PubMed ID: 6108917
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy using beta-receptor blockaders in coronary disease].
    Bolte HD
    Internist (Berl); 1978 Sep; 19(9):520-6. PubMed ID: 29850
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of chronic ischemic heart disease in a public assistance hospital].
    Freitag M; Heinrich HG
    Z Arztl Fortbild (Jena); 1979 Oct; 73(19-20):894-5. PubMed ID: 45158
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of coronary disease with beta-receptor blockaders].
    Lydtin H
    Internist (Berl); 1972 Sep; 13(9):373-9. PubMed ID: 4404225
    [No Abstract]   [Full Text] [Related]  

  • 16. [Conservative treatment of coronary heart disease].
    Bachmann K
    Fortschr Med; 1976 Nov; 94(32):1821-5. PubMed ID: 11160
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of cardiac insufficiency. 2].
    Breithaupt H
    Med Welt; 1979 Sep; 30(38):1383-7. PubMed ID: 39218
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent aspects on basic drug therapy of acute myocardial infarct].
    Erbel R; Belz GG
    Med Klin; 1977 Sep; 72(35):1341-60. PubMed ID: 20560
    [No Abstract]   [Full Text] [Related]  

  • 19. [Principles of modern drug therapy of ischemic heart disease].
    Kaverina NV
    Ter Arkh; 1977; 49(1):22-30. PubMed ID: 17168
    [No Abstract]   [Full Text] [Related]  

  • 20. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1873-9. PubMed ID: 4155950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.